Live corpus
Active intelligence prompt Pediatric cancer: surface high-value therapeutic signals across pediatric oncology literature.
PEDIATRIC CANCER RESEARCH INTELLIGENCE

Finding therapies hidden in 40,136 pediatric cancer papers.

Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.

40,136 Papers indexed
1,440 Papers AI scored
40,136 Ranked papers
100.0% Coverage
PATIENT-FRIENDLY SUMMARY

CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortium.

For education only—not personal medical advice.

LIVE PEDIATRIC ONCOLOGY INTELLIGENCE
↑ Therapeutic signals emerging ↑ New pediatric cancer papers ingested ↑ Cross-paper convergence detected ↑ Human relevance scores updating ↑ Overlooked treatment paths surfacing
TOP PEDIATRIC CANCER SIGNALS

Ranked Discovery Journal Articles

View all discoveries →
LATEST PEDIATRIC CANCER PAPERS

Database feed

Last ingest 2026-11-06 10:15 AM
PEDIATRIC CANCER RESEARCH TERMINAL

All ranked pediatric cancer papers

40136 results
C
Long-term clinical outcomes and recurrence factors in intracranial germinoma.
PMID 42243616 Published: 2026-06-04 Ingested: 2026-08-02 12:07 AM Journal of neuro-oncology
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 70.0; therapeutic relevance: 49.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
[Efficacy of Ganciclovir Combined With Recombinant Human Interferon α-1b for Viral Encephalitis in Children].
PMID 42021910 Published: 2026-03-20 Ingested: 2026-08-02 12:06 AM Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

C
Gamma knife radiosurgery in pediatric neuro-oncology: histology-specific outcomes and age-adapted procedural strategies.
PMID 41979696 Published: 2026-04-14 Ingested: 2026-08-02 12:06 AM Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 34.0; sample size: 60.0; recency: 100.0; abstract quality: 100.0.

C
Endoscopic disconnection of hypothalamic hamartoma: an already outdated story?
PMID 41962169 Published: 2026-04-10 Ingested: 2026-08-02 12:06 AM Journal of neurosurgery. Pediatrics
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 44.0; sample size: 40.0; recency: 100.0; abstract quality: 100.0.

C
Path forward: Cryoablation for colorectal liver metastases.
PMID 41926877 Published: 2026-03-25 Ingested: 2026-08-02 12:06 AM European journal of radiology
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 45.0; human relevance: 85.0; therapeutic relevance: 69.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Risk of Subsequent Primary Melanoma in 68,002 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup cohort study.
PMID 41915055 Published: 2026-03-30 Ingested: 2026-08-02 12:06 AM Journal of the National Cancer Institute
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Optimising door-to-needle-time in children with febrile neutropenia in the paediatric emergency unit-a quality improvement study.
PMID 41877750 Published: 2026-01-20 Ingested: 2026-08-02 12:06 AM Ecancermedicalscience
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

C
Neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome: an important yet overlooked diagnosis in pediatric ataxia.
PMID 41871563 Published: 2026-02-27 Ingested: 2026-08-02 12:06 AM The Turkish journal of pediatrics
AI -
Standard 66.3
Final -
AI Summary

This pediatric cancer paper has not been AI summarized yet.

Why It Matters

Deterministic evidence score: 66.3/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.

Previous
Page 1003 of 3345
Next
Before you continue

AI-assisted research information

Neurocompute uses AI to summarize scientific papers, interpret research signals, and suggest relevant reference links. AI-generated content can be incomplete, misleading, or wrong, and generated links may be irrelevant or unavailable.

Our reviewed outputs have performed strongly to date, but past accuracy is not a guarantee. Verify summaries, scores, claims, and links against the original publication before relying on them.

This platform is for research and education only. It does not provide medical advice, diagnosis, treatment recommendations, or clinical guidance.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic